These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7332609)

  • 21. Probucol further lowers the serum cholesterol of colestipol-treated patients with hypercholesterolemia.
    Schonfeld G; Witztum J; Basich P
    Artery; 1982; 10(2):99-104. PubMed ID: 7092583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of long-term treatment with probucol on serum lipoproteins in cases of familial hypercholesterolemia in the elderly.
    Morisaki N; Mori S; Kobayashi J; Ishikawa Y; Shinomiya M; Shirai K; Saito Y; Yoshida S
    J Am Geriatr Soc; 1990 Jan; 38(1):15-8. PubMed ID: 2295765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoprotein fractions and receptors: a role for probucol?
    Bilheimer DW
    Am J Cardiol; 1986 Jun; 57(16):7H-15H. PubMed ID: 3637051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacology of probucol. I].
    Donatelli L
    Clin Ter; 1984 Mar; 108(5):367-88. PubMed ID: 6232074
    [No Abstract]   [Full Text] [Related]  

  • 25. Mode of action of probucol in reducing serum cholesterol in mice.
    Tawara K; Tomikawa M; Abiko Y
    Jpn J Pharmacol; 1986 Jan; 40(1):123-33. PubMed ID: 3959347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Probucol and cholestyramine combination in the treatment of severe hypercholesterolemia.
    Sommariva D; Bonfiglioli D; Tirrito M; Pogliaghi I; Branchi A; Cabrini E
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):505-10. PubMed ID: 3781686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modifications in the chemical composition and thermometric behavior of LDL and HDL by probucol in type IIa hyperlipoproteinemia.
    Dachet C; Motta C; Neufcour D; Jacotot B
    Adv Exp Med Biol; 1988; 243():179-84. PubMed ID: 3223415
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of probucol, pantethine and their combinations on serum lipoprotein metabolism and on the incidence of atheromatous lesions in the rabbit.
    Tawara K; Ishihara M; Ogawa H; Tomikawa M
    Jpn J Pharmacol; 1986 Jun; 41(2):211-22. PubMed ID: 3747267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probucol-lipid pharmacology.
    Kritchevsky D
    Artery; 1982; 10(1):1-6. PubMed ID: 6807261
    [No Abstract]   [Full Text] [Related]  

  • 30. Effectiveness of probucol in reducing plasma low-density lipoprotein cholesterol oxidation in hypercholesterolemia.
    Masana L; Bargalló MT; Plana N; LaVille A; Casals I; Solà R
    Am J Cardiol; 1991 Oct; 68(9):863-7. PubMed ID: 1927944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probucol with colestipol in the treatment of hypercholesterolemia.
    Dujovne CA; Krehbiel P; Decoursey S; Jackson B; Chernoff SB; Pitterman A; Garty M
    Ann Intern Med; 1984 Apr; 100(4):477-82. PubMed ID: 6367578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose colestipol plus probucol for hypercholesterolemia.
    Dujovne CA; Chernoff SB; Krehbiel P; Jackson B; DeCoursey S; Taylor H
    Am J Cardiol; 1984 Jun; 53(11):1514-8. PubMed ID: 6375337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of probucol on plasma lipids and lipoproteins in type IIb hyperlipoproteinemia.
    Hunninghake DB; Bell C; Olson L
    Atherosclerosis; 1980 Nov; 37(3):469-74. PubMed ID: 7458992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of probucol administration on lipoprotein cholesterol and apolipoproteins in normolipemic males.
    Berg A; Frey I; Baumstark M; Keul J
    Atherosclerosis; 1988 Jul; 72(1):49-54. PubMed ID: 3214458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: effects of apolipoprotein E deficiency and probucol or phytosterol treatment.
    Moghadasian MH; Nguyen LB; Shefer S; Salen G; Batta AK; Frohlich JJ
    Metabolism; 2001 Jun; 50(6):708-14. PubMed ID: 11398149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of medium-term probucol treatment on plasma lipids and lipoproteins. 16 cases of type IIa and IIb hyperlipoproteinaemia (author's transl)].
    Rouffy J; Chanu B; Bakir R; Goy-Loepper J; Saya C
    Nouv Presse Med; 1980 Oct; 9(40):3014-7. PubMed ID: 7443443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probucol reduces hepatic cholesterol secretion in hyperlipidemic Yoshida rats.
    Bravo E; Ortu G; Rivabene R; Santini MT; Cantafora A
    Atherosclerosis; 1996 Jan; 119(2):223-33. PubMed ID: 8808499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of probucol on the levels, structure, composition and metabolism of plasma lipoprotein in rats.
    Eisenberg S
    Biochim Biophys Acta; 1993 Mar; 1167(1):79-84. PubMed ID: 8461336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlative design of electrophoretic and ultracentrifugal investigation of metabolic effects of probucol.
    Opplt JJ; Chick LL; Opplt MA
    Artery; 1982; 10(2):131-49. PubMed ID: 7092580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of probucol on bile composition in man.
    Jirsa M; Marecek Z; Kerdac V; Kucerova L
    Artery; 1982; 10(1):44-7. PubMed ID: 7092575
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.